Clinical Trial Update: Frequency of FCGR3A Gene Polymorphisms in Patients With Neuromyelitis Optica Spectrum Disorders, Anti-oligodendrocyte Myelin Protein Antibody Disease, and Multiple Sclerosis. [NA]

View source ↗

Summary

This clinical trial update reports on the frequency of FCGR3A gene polymorphisms in patients with Neuromyelitis Optica Spectrum Disorders, Myelin oligodendrocyt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis
• Myelin Oligodendrocyte Glycoprotein Antibody-associated Disease
• Neuromyelitis Optica Spectrum Disorders

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Neuromyelitis Optica Spectrum Disorders, MOGAD | NA | Status: RECRUITING